Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Ryan Taft, James LaFrance

Premium

Ryan Taft has joined Illumina as director of scientific research. Taft is laboratory head and senior research fellow at the University of Queensland's Institute for Molecular Bioscience. Taft will maintain a joint appointment with UQ while working for Illumina.


Vermillion has tapped James LaFrance, chairman of the firms' board of directors, to succeed Thomas McLain as president and CEO. LaFrance, who will continue to serve as Vermillion's board chairman, formerly was CEO of Omnyx and held executive leadership posts at Ventana Medical Systems and Bayer Diagnostics.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.